文献速递心外重症与机械循环支持

连续流左心室辅助装置成功撤除后长期成功的预测因素

Predictors of long-term success after successful explantation of continuous flow left ventricular assist device support.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

该研究回顾性分析135例因非缺血性扩张型心肌病接受连续流左心室辅助装置(cf-LVAD)作为心脏移植桥接的成人患者,其中13例心肌恢复后撤除装置。多因素logistic回归显示首次心衰事件至cf-LVAD植入的时间间隔是成功撤除的独立预测因素,最佳截断值为7个月,敏感度91.0%、特异度84.6%。

要点

  • 首次心衰事件至cf-LVAD植入的时间间隔是成功撤除的独立预测因素。
  • 预测cf-LVAD撤除的最佳时间间隔截断值为7个月,敏感度91.0%、特异度84.6%。
  • 成功撤除后6个月左心室功能和尺寸显著改善,撤除后中位30个月全部存活且无因心衰再住院。

核心结论

  • 在非缺血性扩张型心肌病患者中,首次心衰事件至cf-LVAD治疗的时间间隔较短者,左心室心肌可能在装置植入后早期恢复。

研究设计与样本

  • 回顾性识别135例因非缺血性扩张型心肌病接受cf-LVAD作为心脏移植桥接的成人患者,其中13例心肌恢复后撤除装置(恢复组),122例继续cf-LVAD治疗(非恢复组)。

主要发现

  • 多因素logistic回归分析显示首次心衰事件至cf-LVAD植入的时间间隔是成功撤除的独立预测因素。
  • 预测cf-LVAD撤除的最佳时间间隔截断值为7个月,敏感度91.0%、特异度84.6%。
  • 成功撤除cf-LVAD的患者术后6个月超声心动图显示左心室功能和尺寸显著改善。
  • 13例撤除患者目前全部存活,撤除后中位随访30个月(四分位距18-58个月),撤除后因心衰再住院的无生存率为100%。
  • 撤除后左心室功能和重构也得以保持。

关键数值与推荐

  • 13例撤除患者中12例(92%)经weaning方案评估后接受手术撤除。
  • 预测cf-LVAD撤除的最佳时间间隔截断值为7个月,敏感度91.0%、特异度84.6%。

临床怎么用

  • 对于非缺血性扩张型心肌病接受cf-LVAD作为桥接的患者,首次心衰事件至cf-LVAD植入的时间间隔可能有助于预测成功撤除。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Predictors and evaluations of continuous flow left ventricular assist device (cf-LVAD) explantation in recovered patients remain under discussion due to lack of evidence on long-term safety and efficacy. This study summarized our experiences regarding cf-LVAD explantation in non-ischaemic dilated cardiomyopathy patients and estimated a predictor for sufficient myocardial recovery allowing left ventricular assist device explant. METHODS: We retrospectively identified 135 adult patients with cf-LVAD therapy as bridge to heart transplant due to non-ischaemic dilated cardiomyopathy. Of those, 13 patients underwent device explantation (recovery group) after myocardial recovery. Twelve (92%) of the explanted patients were evaluated using our weaning protocol and underwent surgical explantation. Meanwhile, the remaining 122 continued with cf-LVAD therapy (non-recovery group). RESULTS: Multivariate logistic regression analysis revealed time interval between the first heart failure event and cf-LVAD implantation as an independent predictor for successful explantation. The optimal time interval cutoff value to predict cf-LVAD explantation was 7 months, with a sensitivity of 91.0% and specificity of 84.6%. Echocardiography in patients with successful cf-LVAD explantation showed significant improvement of left ventricular function and dimensions at 6 months postoperatively. The 13 explanted patients are currently alive at a median of 30 (interquartile range; 18-58) months after explantation. The survival rate free from rehospitalization due to heart failure following explantation was 100%. Left ventricular function and remodelling after explantation were also preserved. CONCLUSIONS: In non-ischaemic dilated cardiomyopathy patients with a short interval between the first heart failure event and cf-LVAD therapy, left ventricular myocardium may recover in an early phase after device implantation.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Gyoten T, Amiya E, Saito A, et al. Predictors of long-term success after successful explantation of continuous flow left ventricular assist device support. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38830049. doi:10.1093/icvts/ivae091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。